Download PDF
Thromb Haemost 2001; 86(03): 933
DOI: 10.1055/s-0037-1616156
Letters to the Editor
Schattauer GmbH

The Risk of Overdiagnosis of Antiphospholipid Antibody Syndrome

V. Pengo
1   Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova, Italy
,
A. Biasiolo
1   Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova, Italy
› Author Affiliations
Further Information

Publication History

Received 12 March 2001

Accepted after revision 03 April 2001

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
    CrossrefPubMedGoogle Scholar
  • 2 Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-Glycoprotein-I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Autoantibodies to phospholipid binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thomb Haemost 1996; 75: 721-4.
    PubMedGoogle Scholar
  • 4 Rampazzo P, Biasiolo A, Garin J, Rosato A, Betterle C, Ruffatti A, Pengo V. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins. Thromb Haemost 2001; 85: 57-62.
    Article in Thieme ConnectPubMedGoogle Scholar